PAREXEL International Corporation (NASDAQ: PRXL) announced that it has introduced a new web-based technology platform for late phase clinical research to meet the expanding regulatory and commercialization needs of the biopharmaceutical industry. The platform aims to bring greater cost effectiveness to conducting large-scale studies and facilitate efficient capture of global safety and health outcomes data in a real world setting.
The solution integrates the strategies of PAREXEL’s PACE™ (Peri Approval Clinical Excellence) team with eClinical solutions from Perceptive Informatics, PAREXEL’s technology subsidiary.
“Post-approval studies have continued to expand measurably in number, size, and complexity in recent years. As a result, biopharmaceutical companies require much greater efficiency in managing the high volume throughput of data while controlling the costs related to these programs,” said Carol Collins, Ph.D., Corporate Vice President and Worldwide Head of PACE, PAREXEL International.
The platform includes many features to bring greater efficiency to late phase studies, such as:
• A streamlined user experience with single access
• An intuitive interface with functionality for site self registration and management
• Automated cues for unique late phase site requirements
• Enhanced reporting capabilities including site-based features such as investigator payment status reports
• Centralized access to data including site, patient, and clinical supply information
The platform allows for a broad range of eClinical solutions, such as Clinical Trial Management Systems (CTMS), Electronic Data Capture (EDC), Randomization and Trial Supply Management (RTSM), and Electronic Patient-Reported Outcomes (ePRO), to be incorporated in late phase studies for optimal data integration.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.